Ori Biotech, Cy­ti­va sep­a­rate­ly un­veil tech to ac­cel­er­ate cell ther­a­py pro­duc­tion

Two man­u­fac­tur­ing tech de­vel­op­ers have in­de­pen­dent­ly de­tailed their own ap­proach­es that could im­prove the cost and time­lines to make cell and gene ther­a­pies and CAR …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER